Civivi’s Elementum is among the brand’s best-selling knives of all time. In fact, if you add up all of the different versions, it’s also among the most iterated in the brand’s catalog. Yet, the We ...

At the tail-end of last year, Civivi quietly put a prototype knife, called the Kukei, up on its site. The design drew on Japanese history and one of the oldest and most iconic folding knives. However, ...

FDA assigned PDUFA target action date of September 27, 2026 BOSTON, March 30, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous ...

Praxis Precision Medicines' New Drug Application for relutrigine will receive priority review by the Food and Drug Administration. The clinical-stage biopharmaceutical company said Monday that the FDA ...

"This is a classic utility knife for everyday tasks." ...

PRAX is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of PRAX shares has increased $22.11 since the market last closed. This is a 6.90% ...

It looks like slipjoints will be playing a larger role in the Civivi catalog this year. A soon-to-release model, the Aevren, has been designed as a modern, non-locking everyday carry piece. While we ...

NEA created these Praxis blended learning courses to provide additional support to potential and future educators studying for Praxis exams. NEA created these Praxis blended learning courses to ...

Rights Mar 20, 2025 Mar 20, 2025 Nov 11, 2024 Rights ratio: 11 share for every 30 held at a price of Rs 10.0 Rights May 30, 2023 May 30, 2023 Mar 14, 2023 Rights ratio: 13 share for every 20 held at a ...

BOSTON, March 30, 2026 (GLOBE NEWSWIRE)-- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, ...